Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Renpei Kato

Showing results (1-10 of 68) with videos related to

Pageof 7
Sort By:
Expert Review of Anticancer Therapy|January 21, 2025
Persisting challenges in the development of predictive biomarkers for immuno-oncology therapies for renal cell carcinomaRenpei Kato, Wataru Obara
International Journal of Urology : Official Journal of the Japanese Urological Association|June 22, 2017
Recent progress in immunotherapy for urological cancerWataru Obara, Renpei Kato, Yoichiro Kato, et al.
Japanese Journal of Clinical Oncology|April 2, 2014
Efficacy of everolimus in patients with advanced renal cell carcinoma refractory or intolerant to VEGFR-TKIs and safety compared with prior VEGFR-TKI treatmentRenpei Kato, Wataru Obara, Tomohiko Matsuura, et al.
BMC Cancer|March 25, 2017
Characteristics of early-onset hematotoxicity of sunitinib in Japanese patients with renal cell carcinomaRenpei Kato, Yoichiro Kato, Tomohiko Matsuura, et al.
International Cancer Conference Journal|March 25, 2024
A case of postoperative pancreatitis in patients with renal cell carcinoma with an inferior vena cava tumor thrombus treated by presurgical lenvatinib plus pembrolizumabMasahiro Kurokawa, Daiki Ikarashi, Renpei Kato, et al.
Cancer Science|January 19, 2018
Present status and future perspective of peptide-based vaccine therapy for urological cancerWataru Obara, Mitsugu Kanehira, Toyomasa Katagiri, et al.
International Immunopharmacology|November 20, 2022
Site-specific patterns of early response to nivolumab plus ipilimumab therapy in advanced renal cell carcinoma patients compared with tyrosine-kinase inhibitorsRenpei Kato, Tomohiko Matsuura, Shigekatsu Maekawa, et al.
BMC Medical Education|September 22, 2021
Improvement of three-dimensional motion sickness using a virtual reality simulator for robot-assisted surgery in undergraduate medical students: A prospective observational studyRyo Takata, Mitsugu Kanehira, Yoichiro Kato, et al.
Hinyokika Kiyo. Acta Urologica Japonica|September 3, 2010
[Septic shock due to fluoroquinolone-resistant Escherichia coli after trans-rectal prostate needle biopsy]Renpei Kato, Yasushi Suzuki, Tomohiko Matsuura, et al.
Asian Journal of Endoscopic Surgery|March 24, 2022
Concurrent robot-assisted radical prostatectomy and robot-assisted partial nephrectomy for patients with synchronous prostate cancer and small renal tumor: A case series of five patientsMitsugu Kanehira, Daichi Tamura, Tomohiko Matsuura, et al.
Pageof 7

Showing results (1-10 of 68) with videos related to

Sort By:
Pageof 7
Expert Review of Anticancer Therapy|January 21, 2025
Persisting challenges in the development of predictive biomarkers for immuno-oncology therapies for renal cell carcinomaRenpei Kato, Wataru Obara
International Journal of Urology : Official Journal of the Japanese Urological Association|June 22, 2017
Recent progress in immunotherapy for urological cancerWataru Obara, Renpei Kato, Yoichiro Kato, et al.
Japanese Journal of Clinical Oncology|April 2, 2014
Efficacy of everolimus in patients with advanced renal cell carcinoma refractory or intolerant to VEGFR-TKIs and safety compared with prior VEGFR-TKI treatmentRenpei Kato, Wataru Obara, Tomohiko Matsuura, et al.
BMC Cancer|March 25, 2017
Characteristics of early-onset hematotoxicity of sunitinib in Japanese patients with renal cell carcinomaRenpei Kato, Yoichiro Kato, Tomohiko Matsuura, et al.
International Cancer Conference Journal|March 25, 2024
A case of postoperative pancreatitis in patients with renal cell carcinoma with an inferior vena cava tumor thrombus treated by presurgical lenvatinib plus pembrolizumabMasahiro Kurokawa, Daiki Ikarashi, Renpei Kato, et al.
Cancer Science|January 19, 2018
Present status and future perspective of peptide-based vaccine therapy for urological cancerWataru Obara, Mitsugu Kanehira, Toyomasa Katagiri, et al.
International Immunopharmacology|November 20, 2022
Site-specific patterns of early response to nivolumab plus ipilimumab therapy in advanced renal cell carcinoma patients compared with tyrosine-kinase inhibitorsRenpei Kato, Tomohiko Matsuura, Shigekatsu Maekawa, et al.
BMC Medical Education|September 22, 2021
Improvement of three-dimensional motion sickness using a virtual reality simulator for robot-assisted surgery in undergraduate medical students: A prospective observational studyRyo Takata, Mitsugu Kanehira, Yoichiro Kato, et al.
Hinyokika Kiyo. Acta Urologica Japonica|September 3, 2010
[Septic shock due to fluoroquinolone-resistant Escherichia coli after trans-rectal prostate needle biopsy]Renpei Kato, Yasushi Suzuki, Tomohiko Matsuura, et al.
Asian Journal of Endoscopic Surgery|March 24, 2022
Concurrent robot-assisted radical prostatectomy and robot-assisted partial nephrectomy for patients with synchronous prostate cancer and small renal tumor: A case series of five patientsMitsugu Kanehira, Daichi Tamura, Tomohiko Matsuura, et al.
Pageof 7